SEOM clinical guidelines in early stage breast cancer (2018)

被引：53

作者：

Ayala de la Pena, F. ^{[1
]}

Andres, R. ^{[2
]}

Garcia-Saenz, J. A. ^{[3
]}

Manso, L. ^{[4
]}

Margeli, M. ^{[5
]}

Dalmau, E. ^{[6
]}

Pernas, S. ^{[7
]}

Prat, A. ^{[8
]}

Servitja, S. ^{[9
]}

Ciruelos, E. ^{[10
,11
]}

机构：

[1] Hosp G Univ Morales Meseguer, Dept Hematol & Med Oncol, Avda Marques Velez S-N, Murcia 30001, Spain

[2] Hosp Clin Univ Lozano Blesa, Div Med Oncol, Zaragoza, Spain

[3] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain

[4] Univ Hosp, Dept Med Oncol, 12 Octubre, Madrid, Spain

[5] Inst Catala Oncol, Dept Med Oncol, Breast Canc Unit, BARGO Grp, Badalona, Spain

[6] Univ Hosp, Dept Oncol, Parc Tauli Sabadell, Barcelona, Spain

[7] Inst Catala Oncol, Dept Med Oncol, Breast Canc Unit, Barcelona, Spain

[8] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[9] Hosp del Mar, Dept Med Oncol, Barcelona, Spain

[10] Univ Hosp, Dept Med Oncol, Breast Canc Unit, 12 Octubre, Madrid, Spain

[11] HM Hosp, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2019年 / 21卷 / 01期

关键词：

Early breast cancer; Adjuvant; Neoadjuvant; Genomic predictive test; Follow-up; 21-GENE RECURRENCE SCORE; NEOADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; ADJUVANT TAMOXIFEN; DISTANT RECURRENCE; FOLLOW-UP; PAM50; RISK; OPEN-LABEL; PROGNOSTIC-FACTORS; RADIATION-THERAPY;

D O I：

10.1007/s12094-018-1973-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.

引用

页码：18 / 30

页数：13

共 90 条

[21] Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement [J].

Correa, Candace ;

Harris, Eleanor E. ;

Leonardi, Maria Cristina ;

Smith, Benjamin D. ;

Taghian, Alphonse G. ;

Thompson, Alastair M. ;

White, Julia ;

Harris, Jay R. .

PRACTICAL RADIATION ONCOLOGY, 2017, 7 (02) :73-79

[22] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[23] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 [J].

Curigliano, G. ;

Burstein, H. J. ;

Winer, E. P. ;

Gnant, M. ;

Dubsky, P. ;

Loibl, S. ;

Colleoni, M. ;

Regan, M. M. ;

Piccart-Gebhart, M. ;

Senn, H. -J. ;

Thurlimann, B. ;

Andre, F. ;

Baselga, J. ;

Bergh, J. ;

Bonnefoi, H. ;

Brucker, S. Y. ;

Cardoso, F. ;

Carey, L. ;

Ciruelos, E. ;

Cuzick, J. ;

Denkert, C. ;

Di Leo, A. ;

Ejlertsen, B. ;

Francis, P. ;

Galimberti, V. ;

Garber, J. ;

Gulluoglu, B. ;

Goodwin, P. ;

Harbeck, N. ;

Hayes, D. F. ;

Huang, C. -S. ;

Huober, J. ;

Khaled, H. ;

Jassem, J. ;

Jiang, Z. ;

Karlsson, P. ;

Morrow, M. ;

Orecchia, R. ;

Osborne, K. C. ;

Pagani, O. ;

Partridge, A. H. ;

Pritchard, K. ;

Ro, J. ;

Rutgers, E. J. T. ;

Sedlmayer, F. ;

Semiglazov, V. ;

Shao, Z. ;

Smith, I. ;

Toi, M. ;

Tutt, A. .

ANNALS OF ONCOLOGY, 2017, 28 (08) :1700-1712

[24]

Cuzick J, 2007, LANCET, V369, P1711

[25] Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].

Davies, C. ;

Godwin, J. ;

Gray, R. ;

Clarke, M. ;

Darby, S. ;

McGale, P. ;

Wang, Y. C. ;

Peto, R. ;

Pan, H. C. ;

Cutter, D. ;

Taylor, C. ;

Ingle, J. .

LANCET, 2011, 378 (9793) :771-784

[26] Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [J].

Davies, Christina ;

Pan, Hongchao ;

Godwin, Jon ;

Gray, Richard ;

Arriagada, Rodrigo ;

Raina, Vinod ;

Abraham, Mirta ;

Medeiros Alencar, Victor Hugo ;

Badran, Atef ;

Bonfill, Xavier ;

Bradbury, Joan ;

Clarke, Michael ;

Collins, Rory ;

Davis, Susan R. ;

Delmestri, Antonella ;

Forbes, John F. ;

Haddad, Peiman ;

Hou, Ming-Feng ;

Inbar, Moshe ;

Khaled, Hussein ;

Kielanowska, Joanna ;

Kwan, Wing-Hong ;

Mathew, Beela S. ;

Mittra, Indraneel ;

Mueller, Bettina ;

Nicolucci, Antonio ;

Peralta, Octavio ;

Pernas, Fany ;

Petruzelka, Lubos ;

Pienkowski, Tadeusz ;

Radhika, Ramachandran ;

Rajan, Balakrishnan ;

Rubach, Maryna T. ;

Tort, Sera ;

Urrutia, Gerard ;

Valentini, Miriam ;

Wang, Yaochen ;

Peto, Richard .

LANCET, 2013, 381 (9869) :805-816

[27] Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial [J].

Derks, Marloes G. M. ;

Blok, Erik J. ;

Seynaeve, Caroline ;

Nortier, Johan W. R. ;

Kranenbarg, Elma Meershoek-Klein ;

Liefers, Gerrit-Jan ;

Putter, Hein ;

Kroep, Judith R. ;

Rea, Daniel ;

Hasenburg, Annette ;

Markopoulos, Christos ;

Paridaens, Robert ;

Smeets, Jan B. E. ;

Dirix, Luc Y. ;

van de Velde, Cornelis J. H. .

LANCET ONCOLOGY, 2017, 18 (09) :1211-1220

[28] Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline [J].

Dhesy-Thind, Sukhbinder ;

Fletcher, Glenn G. ;

Blanchette, Phillip S. ;

Clemons, Mark J. ;

Dillmon, Melissa S. ;

Frank, Elizabeth S. ;

Gandhi, Sonal ;

Gupta, Rasna ;

Mates, Mihaela ;

Moy, Beverly ;

Vandenberg, Ted ;

Van Poznak, Catherine H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) :2062-+

[29] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial [J].

Donker, Mila ;

van Tienhoven, Geertjan ;

Straver, Marieke E. ;

Meijnen, Philip ;

van de Velde, Cornelis J. H. ;

Mansel, Robert E. ;

Cataliotti, Luigi ;

Westenberg, A. Helen ;

Klinkenbijl, Jean H. G. ;

Orzalesi, Lorenzo ;

Bouma, Willem H. ;

van der Mijle, Huub C. J. ;

Nieuwenhuijzen, Grard A. P. ;

Veltkamp, Sanne C. ;

Slaets, Leen ;

Duez, Nicole J. ;

de Graaf, Peter W. ;

van Dalen, Thijs ;

Marinelli, Andreas ;

Rijna, Herman ;

Snoj, Marko ;

Bundred, Nigel J. ;

Merkus, Jos W. S. ;

Belkacemi, Yazid ;

Petignat, Patrick ;

Schinagl, Dominic A. X. ;

Coens, Corneel ;

Messina, Carlo G. M. ;

Bogaerts, Jan ;

Rutgers, Emiel J. T. .

LANCET ONCOLOGY, 2014, 15 (12) :1303-1310

[30] Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy [J].

Dowsett, Mitch ;

Sestak, Ivana ;

Lopez-Knowles, Elena ;

Sidhu, Kalvinder ;

Dunbier, Anita K. ;

Cowens, J. Wayne ;

Ferree, Sean ;

Storhoff, James ;

Schaper, Carl ;

Cuzick, Jack .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) :2783-+

← 1 2 3 4 5 6 7 8 9 →